Background Neurostimulation of the subthalamic nucleus reduces levodopa-related motor
complications in advanced Parkinson's disease. We compared this treatment plus medication …

Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria,
published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for …

Many patients with assumed idiopathic REM sleep behavior disorder (RBD) may actually
represent an early clinical manifestation of an evolving neurodegenerative disorder, such as …

Loss of noradrenergic locus coeruleus (LC) neurons is a prominent feature of aging-related
neurodegenerative diseases, such as Parkinson's disease (PD). The basis of this …

Annonacin, a natural lipophilic inhibitor of mitochondrial complex I has been implicated in the
etiology of a sporadic neurodegenerative tauopathy in Guadeloupe. We therefore studied …

This document presents the Movement Disorder Society Clinical Diagnostic Criteria for
Parkinson's disease (PD). The Movement Disorder Society PD Criteria are intended for use in …

A large International Restless Legs Syndrome (RLS) Study Group has been formed. As its
first task, the group has taken upon itself the role of definig the clinical features of the RLS. As …

This article describes research criteria and probability methodology for the diagnosis of
prodromal PD. Prodromal disease refers to the stage wherein early symptoms or signs of PD …

Cerebral dopamine depletion is the hallmark of Parkinson disease. Because dopamine
modulates ontogenetic neurogenesis, depletion of dopamine might affect neural precursors in …

Idiopathic Parkinson's disease (PD) is a neurodegenerative disorder associated with akinesia,
tremor and rigidity. While the characteristic Lewy body pathology targets pigmented and …